Abstract
Dyslipidemia is one of the key features in the pathogenesis of atherosclerosis, however, many points in the progression of this pathological phenomenon remain unclear. In this review, we will consider the significance of various lipoproteins in the progression of atherosclerosis, the general pattern of dyslipidemia development and its role in the pathogenesis of atherosclerosis, as well as new approaches to the treatment of dyslipidemia, which will potentially reduce the disadvantages of existing therapies and increase drug efficacy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
